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We report a case of a 66-year-old diabetic patient who presented with muscle weakness 2
weeks after kidney transplantation. Her immunosuppressive regimen included tacrolimus,
mycophenolate mofetil, and steroids. She was found to have hyperkalemia and normal
anion gap metabolic acidosis. Tacrolimus levels were in therapeutic range. All other drugs
such as beta blockers and trimethoprim e sulfamethoxazole were stopped. She did not
respond to routine antikalemic measures. Further evaluation revealed type 4 renal tubular
acidosis. Serum potassium levels returned to normal after starting sodium bicarbonate and
fludrocortisone therapy. Though hyperkalemia is common in kidney transplant recipients,
determining exact cause can guide specific treatment.Incidence of hyperkalemia in kidney transplant recipients
who receive calcineurin inhibitors is about 44% [1]. Ischemia,
tubular necrosis, rejection, and drugs are some of the com-
mon causes of hyperkalemia. Determining exact cause can
guide specific treatment. We describe a case of kidney trans-
plant recipient who had persistent hyperkalemia due to type 4
renal tubular acidosis (RTA) and was treated with flu-
drocortisone and sodium bicarbonate therapy.
A 66-year-old female diabetic patient presented 2 weeks
after kidney transplantation with muscle weakness. Her
medications included tacrolimus, mycophenolate mofetil,
prednisolone, trimethoprim-sulfamethoxazole, and carve-
dilol. Her laboratory reports showed serum creatinine
0.6 mg/dl, serum sodium 135 mEq/L, serum potassiumrology, Father Muller Med
.
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).6.5 mEq/L, serum chloride 110 mEq/L, and serum bicarbon-
ate 18 mEq/L.
We stopped co-trimoxazole and carvedilol. She was star-
ted on frusemide, oral potassium binding resins, and oral
sodium bicarbonate. Serum tacrolimus levels were 7.1 ng/L.
Repeat serum potassium reading was 7 mEq/L. Further eval-
uation showed urine pH 5.1, urine sodium 40 mEq/L, urine
potassium 30mEq/L, and urine chloride 50 mEq/L. The serum
anion gap was 7 mEq/L and urinary anion gap was 20 mEq/L.
Hyperkalemia distal RTA was ruled out as urinary pH was
<5.5. A normal anion gap metabolic acidosis, positive urinary
anion gap with a urine pH of <5.5 was suggestive of type 4
RTA. We started the patient on fludrocortisone 0.1 mg/day.
Serum potassium levels on consecutive days were 5.8 mEq/L,
5.1 mEq/L, and 4.5 mEq/L. Fludrocortisone was graduallyical College, Father Muller Rd., Kankanady, Mangaluru, Karnataka
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mokalemic at follow-up.
Though there are a few case reports, exact prevalence of
type 4 RTA in kidney transplant recipients in early post-
transplant period is not known [2,3]. In one study of 109 kid-
ney transplant recipients, RTA was seen in 36 patients and
only 3 of these patients had type 4 RTA. Late after transplant,
incidence of type 4 RTA in late transplant period can be as high
as 28% [4,5].
In this case, type 4 RTAwas probably a result of tacrolimus-
induced aldosterone resistance of renal tubules. Finding the
etiology of hyperkalemiawillmake specific treatment possible.Source of support
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